Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Yajin, Chen"'
Autor:
Juxian Sun, Qiu Li, Xueli Bai, Jianqiang Cai, Yajin Chen, Minshan Chen, Chaoliu Dai, Chihua Fang, Weidong Jia, Xiangcheng Li, Tianfu Wen, Jinglin Xia, Mingang Ying, Zhiwei Zhang, Xuewen Zhang, Zhaochong Zeng, Shuqun Cheng, On behalf of Chinese Association of Liver Cancer and Chinese Medical Doctor Association, Sihan Zhou, Xiuyuan Hao
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 21, Pp 2630-2632 (2024)
Externí odkaz:
https://doaj.org/article/5db04210d86f4812889c45f130138f85
Autor:
Haihong Zhu, Xuan Luo, Zhixian Sun, Yonglin Hua, Yuxin Xiao, Huilong Li, Xiaowu Ma, Wenliang Tan, Zhiqin Xie, Ziyu Zhang, Chenwei Tang, Hongkai Zhuang, Weikai Xu, Yajin Chen, Changzhen Shang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Lenvatinib plus PD-1 inhibitors and interventional (LPI) therapy have demonstrated promising treatment effects in unresectable hepatocellular carcinoma (HCC). However, biomarkers for predicting the response to LPI therapy remain to be furt
Externí odkaz:
https://doaj.org/article/57a56a4bbbd5444b83fceec327482060
Autor:
Chenwei Tang, Hongkai Zhuang, Wentao Wang, Qingbin Wang, Xiaowu Ma, Bingkun Wang, Ziyu Zhang, Jiahao Jiang, Zhiqin Xie, Wenliang Tan, Lei Yang, Songyao Liu, Yonglin Hua, Yuxin Xiao, Baoshan Ding, Yajin Chen, Changzhen Shang
Publikováno v:
Cell Death and Disease, Vol 15, Iss 3, Pp 1-15 (2024)
Abstract Circular RNAs (circRNAs) have been implicated in tumorigenesis and progression of various cancers. However, the underlying mechanisms of circRNAs in hepatocellular carcinoma (HCC) have not been fully elucidated. Herein, a new oncogenic circR
Externí odkaz:
https://doaj.org/article/cc0e1d636b0c4c09af75550ab5b6f74f
Autor:
Hongkai Zhuang, Zedan Zhang, Bo Chen, Chenwei Tang, Xinming Chen, Wenliang Tan, Lei Yang, Zhiqin Xie, Xiaowu Ma, Qingbin Wang, Bingkun Wang, Changzhen Shang, Yajin Chen
Publikováno v:
Journal of Big Data, Vol 10, Iss 1, Pp 1-18 (2023)
Abstract Hepatocellular carcinoma (HCC) has a desmoplastic and hypoxic tumor microenvironment (TME), resulting in poor prognosis and treatment resistance. This study aimed to construct a novel prognostic classifier to investigate the degree of hypoxi
Externí odkaz:
https://doaj.org/article/1c360d248b6544aca0016575ef4643bf
Autor:
Wenliang Tan, Kelin Zhang, Xinming Chen, Lei Yang, Sicong Zhu, Yingcheng Wei, Zhiqin Xie, Yajin Chen, Changzhen Shang
Publikováno v:
Journal of Advanced Research, Vol 44, Iss , Pp 173-183 (2023)
Introduction: Lenvatinib has recently become available as the first-line therapy for advanced hepatocellular carcinoma (HCC), but its molecular mechanism in HCC remains largely unknown. Objectives: The current study aims to identify the molecular mec
Externí odkaz:
https://doaj.org/article/e3cf10af10d14fd3a4630edb349b0f00
Autor:
Lei Yang, Wenliang Tan, Yingcheng Wei, Zhiqin Xie, Wenxin Li, Xiaowu Ma, Qingbin Wang, Huilong Li, Ziyu Zhang, Changzhen Shang, Yajin Chen
Publikováno v:
Cell Death and Disease, Vol 13, Iss 5, Pp 1-11 (2022)
Abstract Circular RNAs have been reported to play essential roles in the tumorigenesis and progression of various cancers. However, the biological processes and mechanisms involved in hepatocellular carcinoma (HCC) remain unclear. Initial RNA-sequenc
Externí odkaz:
https://doaj.org/article/10bedf23e25e486c8c9368b987a3b047
Autor:
Zhenggang Ren, Michel Ducreux, Ghassan K. Abou-Alfa, Philippe Merle, Weijia Fang, Julien Edeline, Zhiwei Li, Lihua Wu, Eric Assenat, Sheng Hu, Lorenza Rimassa, Tao Zhang, Jean-Frédéric Blanc, Hongming Pan, Paul Ross, Chia-Jui Yen, Albert Tran, Guoliang Shao, Mohamed Bouattour, Yajin Chen, Tim Meyer, Jinlin Hou, David Tougeron, Yuxian Bai, Ming-Mo Hou, Zhiqiang Meng, John Wu, Vincent Li, Sandra Chica-Duque, Ann-Lii Cheng
Publikováno v:
Liver Cancer (2022)
Introduction: Tislelizumab (anti-programmed cell death protein 1 antibody) showed preliminary antitumor activity and tolerability in patients with advanced solid tumors, including hepatocellular carcinoma (HCC). This study aimed to assess the efficac
Externí odkaz:
https://doaj.org/article/5702df6d3dcb4d41bb1056d2e8bdf177
Autor:
Wenliang Tan, Xuan Luo, Wenda Li, Jinyi Zhong, Jun Cao, Sicong Zhu, Xianqing Chen, Rui Zhou, Changzhen Shang, Yajin Chen
Publikováno v:
EBioMedicine, Vol 80, Iss , Pp 104074- (2022)
Externí odkaz:
https://doaj.org/article/547dbd786bdf4809b85f76491e942cc5
Autor:
Hongkai Zhuang, Bo Chen, Chenwei Tang, Xinming Chen, Wenliang Tan, Lei Yang, Zhiqin Xie, Xiaowu Ma, Qingbin Wang, Chuanzhao Zhang, Changzhen Shang, Yajin Chen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundSmith-like (LSM) family members play critical roles in multiple oncologic processes in several types of malignancies. The study on LSM family members of HCC might provide new insights into the tumorigenesis and therapeutic strategies of HCC
Externí odkaz:
https://doaj.org/article/81263b789dc0435bacd36b7d5d238059
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Background: The molecular pathways along with the clinical significance of long non-coding RNAs (lncRNAs) in hepatocellular carcinoma (HCC) remain uncertain. Our study sought to identify and characterize lncRNAs associated with HCC.Methods: LncRNA TM
Externí odkaz:
https://doaj.org/article/2b0a5a2646494aef9b47f811163944ff